Skip to content

Innovative Endotracheal Tube Design Reduces Postoperative Laryngeal Injury

Innovative Endotracheal Tube Design Reduces Postoperative Laryngeal Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06108271
Acronym
Triglotix®
Enrollment
68
Registered
2023-10-30
Start date
2023-10-01
Completion date
2023-11-15
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bucking, Anesthesia Related, Cough, Hoarseness, Intubation Complication, Laryngeal Injury, Sore-throat

Keywords

Laryngeal Injury, Endotracheal tube, General anesthesia

Brief summary

The goal of this randomized clinical trial is to compare two different orotracheal tubes in patients which require orotracheal intubation for general anesthesia. The main questions it aims to answer are: * To assess the presence of laryngeal injury * To evaluate the consequences in voice quality * To ask for the presence of symptoms as sore throat, hoarseness, and cough Participants will be randomly assigned into two groups, one will use conventional endotracheal tube and the other will use Triglotix® endotracheal tube.

Detailed description

Endotracheal intubation is necessary in some patients undergoing surgical procedures and patients requiring mechanical ventilation in the intensive care unit. However, endotracheal intubation is associated with known complications. In post-surgical patients subjected to orotracheal intubation, the incidence of dysphagia, sore throat, hoarseness and cough is 43%,38%27%,32% respectivelly. These figures increase in cases of prolonged intubation, such as those in intensive care units, where reported rates are 76% for sore throat, 63% for hoarseness and 49% for dysphagia. No significant endotracheal tube design improvements have been developed over the past few decades addressing these issues. The present study aims to compare the incidence of laryngeal injuries, and related symptoms as sore throat, hoarseness, swallowing problems, bucking and coughing between two defined sample populations: those utilizing a conventional endotracheal tube (ETT-C) and those employing the new Triglotix® endotracheal tube (ETT-T) in patients undergoing elective surgery requiring general anesthesia and mechanical ventilation.

Interventions

DEVICETriglotix®

The Triglotix® has a biocompatible self-expanding viscoelastic cuff that is located in the supraglottic, glottic and subglottic space. This cuff separates the endotracheal tube from the laryngeal vestibule in the supraglottic space and the vocal cords avoiding direct tissue damage from the plastic components of the tube. The viscoelastic cuff self-expands after the endotracheal tube is in adequate position in the airway. Then it adapts progressively and gradually to the shape of structures it comes in contact with, applying minimal pressure to the surrounding tissue. The ETT-T also has two wire reinforced segments: the first is located outside the mouth to prevent deformation related with kinking, while the second segment is positioned distally along the larynx. The primary purpose of this design is to mitigate torsional, rotational and lateralization forces that the tube may encounter while the patient is intubated.

Conventional endotracheal tube that is currently used worldwide

Sponsors

University Hospital of the Nuestra Señora de Candelaria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Elective perianal surgery requiring intubation for general anesthesia * Duration range 30-90 minutes

Exclusion criteria

* Difficult airway * American Society of Anesthesiologists physical status (ASA) \> III * Morbid obesity (body mass index \>40 kg/m2) * Patients not suitable for outpatient surgery * Patients with history of previous neck surgery * Patients with history of dysphagia * Patients with comorbidities as diabetes and hypertension.

Design outcomes

Primary

MeasureTime frameDescription
Laryngeal injuryImmediately before the induction and 45 minutes after the end of the procedureLaryngeal pathology was assessed based on the location (unilateral: right/left or bilateral) and on morphology: grade 0 = no lesions, grade 1 = superficial erythema (redness of the mucosa without surrounding inflammation), grade 2 = oedema (swollen mucosa at the vocal cords), grade 3 haematoma (redness of the mucosa with surrounding inflammatory swelling), grade 4 = mucosal laceration (causing active bleeding into the vocal cords), grade 5 = arytenoid dislocation or subluxation (arytenoid with limited movement), and grade 6 = vocal cord palsy

Secondary

MeasureTime frameDescription
Bucking during extubationDuring extubationPresence of bucking during extubation assessed by the anesthesiologist just after stimulating the patient (1 = mild, 2 = severe, 3 = abscense)
Postoperative cough45 minutes after the end of the procedurePostoperative cough was assessed: (0 = None, 1 = mild cough, 2 = moderate cough \<5 s, 3 = Severe cough \>5 s)
Acoustic Voice Quality Index 03.01 (AVQIv3)Immediately before the induction and 45 minutes after the end of the procedureConcatenated voice samples of 3 seconds of sv \[a:\] and voiced segments of a phonetically balanced text.
Acoustic Breathiness Index (ABI)Immediately before the induction and 45 minutes after the end of the procedureConcatenated voice samples of 3 seconds of sv \[a:\] and voiced segments of a phonetically balanced text.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026